Utah People's Post

The Latest News from the Beehive State

Wednesday, May 18, 2022
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Archives for FDA

FDA nod to Eli Lilly’s angiogenesis inhibitor Cyramza to treat stomach cancers in advance stage

April 22, 2014 Posted by Contributor

The U.S. Food and Drug Administration (FDA) has given its green signal to Eli Lilly's angiogenesis inhibitor Cyramza (ramucirumab) to treat stomach cancer (in advanced stage) or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach. “Although the rates of stomach cancer in the United States have decreased over the past 40 years, … [Read more...]

Filed Under: Health Tagged With: Cyramza, Eli Lilly's angiogenesis inhibitor, FDA, gastroesophageal junction adenocarcinoma, stomach cancer

FDA : Sarepta’s Eteplirsen drug for treating Duchenne muscular dystrophy

April 21, 2014 Posted by Staff

The Food & Drug Administration (FDA) has given ray of hope to Sarepta Therapeutics by agreeing to consider its experimental drug for Duchenne muscular dystrophy for accelerated approval. Sarept’s eteplirsen is a new intravenous drug known to stabilize the symptoms of a rare and fatal form of muscular dystrophy known as Duchenne. Expressing confidence in positive FDA decision, Sarepta … [Read more...]

Filed Under: Health Tagged With: Duchenne muscular dystrophy, eteplirsen, FDA, Food & Drug Administration, Sarepta, Sarepta drug, Sarpeta, Sarpeta drug

FDA gives green signal to Ragwitek to treat pollen allergies, hay fever

April 19, 2014 Posted by Contributor

The Food and Drug Administration (FDA) has given its green signal to Ragwitek, an allergen extract, to treat short ragweed pollen induced allergic rhinitis or hay fever. The drug, administered under the tongue, helps in treating hay fever (with or without conjunctivitis) in those in age group 18 and 65. Ragwitek contains an extract from short ragweed (Ambrosia artemisiifolia) pollen. One … [Read more...]

Filed Under: Health Tagged With: Allergy, FDA, Food and Drug Administration, hay fever, pollen, Pollen allergies, Pollen allergies cure tips, Ragwitek

Congressional report bats for stringent regulation of Electronic Cigarettes

April 15, 2014 Posted by Contributor

Electronic cigarettes are considered as a good way to quit smoking or a better and healthy alternative to traditional cigarettes. But their rampant use among the Americans especially the teens have raised concerns among the lawmakers and researchers as they are finding health woes related to it. A new Congressional report has mentioned many of the same concerns about these modern cigarettes as … [Read more...]

Filed Under: Health Tagged With: Congressional report, E-cigarettes, Electronic Cigarettes, Electronic cigarettes health woes, FDA, quit smoking

FDA gives nod to user-friendly auto-injector Evzio for heroin overdose antidote

April 4, 2014 Posted by Contributor

Taking note of the rise in deaths from heroin and other drug overdoses, the Food and Drug Authority (FDA) has given its approval to a new hand-held medical device called Evzio, that delivers a life-saving heroin and painkiller antidote called naloxone. The agency has approved the prescription treatment after just 15 weeks under priority status. The hand-held auto-injector is designed in such … [Read more...]

Filed Under: Health Tagged With: auto-injector Evzio, Evzio, FDA, heroin overdose antidote

FDA gives approval to Stallergenes’ immunotherapy drug Oralair

April 2, 2014 Posted by Contributor

The US Food and Drug Administration (FDA) has given green signal to Stallergenes’ immunotherapy drug Oralair for treating grass allergies. It is the first oral immunotherapy pill for treating grass allergies that has been approved in the United States. The drug harnesses the immune system to make you free of allergies and is an alternative to current injectable treatments. The pill is a … [Read more...]

Filed Under: Health Tagged With: FDA, Oralair, Stallergenes, Stallergenes’ immunotherapy drug

FDA advisory panel recommends two new antibiotics Dalvance, Sivextro

April 1, 2014 Posted by Contributor

The advisory committee of US Food and Drug Administration (FDA) has given its nod to two new antibiotics Durata Therapeutics's Dalvance and Cubist Pharmaceuticals's Sivextro. The anti-infective drugs advisory committee of FDA unanimously recommended the approval of two new antibiotics on Monday. One of the panel member Thomas A. Moore said, "It's (Dalvance) a highly effective drug, as … [Read more...]

Filed Under: Health Tagged With: antibiotics, Cubist Pharmaceuticals, Dalvance, Durata Therapeutics, FDA, Sivextro, US Food and Drug Administration

Novartis plans to approach FDA as its Plaque psoriasis drug clears trial

March 22, 2014 Posted by Contributor

Swiss drugmaker Novartis on Saturday said that its experimental drug secukinumab proved to be more effective than Enbrel at clearing psoriasis in a phase III clinical trial. According to the firm, the drug showed good results in a two late-stage clinical trials when used by patients suffering from moderate-to-severe plaque psoriasis. The study findings were presented at the American Academy … [Read more...]

Filed Under: Health Tagged With: FDA, Novartis, Plaque psoriasis, secukinumab

‘Cefaly’ headband-like device to prevent migraines gets FDA nod

March 12, 2014 Posted by Contributor

The US Food and Drug Administration (FDA) has given green signal to first medical device that aims to treat migraine headaches. A nerve-stimulating headband received the approval by FDA as the first medical device to prevent migraine headaches. According to the FDA, the device provides a new trustable option for patients having unbearable migraine medications. The new migraine prevention … [Read more...]

Filed Under: Health Tagged With: Cefaly, device to prevent headaches, FDA, headache, migraine pain, migraines

Regeneron and Sanofi’s new cholesterol drug under FDA scanner

March 8, 2014 Posted by Contributor

Sensing the probable side effects of cholesterol drug, Sanofi, the Food and Drug Administration (FDA) has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess the neurocognitive side effects of their experimental medicine. FDA says, "The agency is aware of concerns raised with neurocognitive adverse events and other lipid-lowering therapies, including statins, and as part of our … [Read more...]

Filed Under: Health Tagged With: cholesterol drug, FDA, Regeneron Pharmaceuticals Inc and Sanofi SA

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

June 29, 2018 By Amelia Donovan

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

June 29, 2018 By Amelia Donovan

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

June 28, 2018 By Amelia Donovan

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

June 27, 2018 By Amelia Donovan

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

June 27, 2018 By Amelia Donovan

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

June 26, 2018 By Amelia Donovan

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

June 25, 2018 By Amelia Donovan

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

June 23, 2018 By Amelia Donovan

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

June 22, 2018 By Amelia Donovan

456 People Dead at U.K. Hospital after Taking too Many Painkillers

June 21, 2018 By Amelia Donovan

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

June 20, 2018 By Amelia Donovan

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2022 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact